BC-05 is a potent inhibitor of CD13 and the 20S proteasome, exhibiting an IC50 of 0.13 μM for human CD13 and 1.39 μM for the proteasome. This compound is orally active and serves as a valuable tool in the investigation of multiple myeloma and related hematological malignancies. Its dual-targeting mechanism makes BC-05 a significant reagent for elucidating pathways involved in cancer progression and therapeutic resistance.
BC-05 is a potent inhibitor of CD13 and the 20S proteasome, exhibiting an IC50 of 0.13 μM for human CD13 and 1.39 μM for the proteasome. This compound is orally active and serves as a valuable tool in the investigation of multiple myeloma and related hematological malignancies. Its dual-targeting mechanism makes BC-05 a significant reagent for elucidating pathways involved in cancer progression and therapeutic resistance.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: